DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Infinium Pharmachem Limited — Board Meeting Intimation

NSE 44 min ago·27 Oct 2026, 12:54 pm

Infinium Pharmachem

Infinium Pharmachem has announced a board meeting scheduled for November 6, 2026. The primary agenda for this session is to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026.

This announcement is a routine corporate disclosure, but it is significant for investors as it provides the first glimpse into the company's financial health for the new fiscal period. The results will likely offer insights into operational performance and profitability trends.

Investors should watch for the release of these results to gauge the company's current trajectory. Any positive or negative surprises in the numbers could influence the stock's short-term price movement.